Among these metabolic disorders, activation of the IGF/IGF-1R axis, which is caused by insulin resistance and hyperinsulinemia, is considered to play a key role in liver carcinogenesis in patients with metabolic syndrome [7,8,9]. Here, IGF1R is linked to metabolic syndrome.